Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

5 more countries OK Pfizer's Xeljanz
Yahoo/AP
Tuesday, July 16, 2013 - 9:25am
tags:
Pfizer, rheumatoid arthritis, Xeljanz
Abbott Labs Earnings Have a Lot of Catching Up to Do
Motley Fool
Tuesday, July 16, 2013 - 9:24am
tags:
earnings, Abbott Laboratories
Police Say Sexual Favors Spur $1.5 Billion Glaxo China Sales
Bloomberg
Tuesday, July 16, 2013 - 9:23am
tags:
China, GSK
J&J results beat expectations, as drugs, devices deliver
Reuters
Tuesday, July 16, 2013 - 9:22am
tags:
earnings, JNJ
Tranzyme announces completion of merger with Ocera Therapeutics
Yahoo/Fly on the Wall
Monday, July 15, 2013 - 2:23pm
tags:
Tranzyme, Ocera Therapeutics, M&A
Peregrine's 4Q Loss In Line
Yahoo/Zacks
Monday, July 15, 2013 - 1:40pm
tags:
earnings, Peregrine Pharmaceuticals
Novartis (NVS) Profit Expected to Slip
Forbes
Monday, July 15, 2013 - 1:31pm
tags:
Novartis, earnins
Drug Approvals Keep Coming for Pfizer
Wall St. Cheat Sheet
Monday, July 15, 2013 - 12:52pm
tags:
Xeljanz, drug approvals, Pfizer
The Best- And Worst-Performing Biotech Stocks July 5 To July 12
Forbes
Monday, July 15, 2013 - 11:21am
tags:
Vivus, Trius Therapeutics, Prosensa, Pharmacyclics, NxStage Medical, Natus Medical, MiMedx, Merrimack Pharmaceuticals, Intuitive Surgical, InterMune, GTx, Fluidigm, Epizyme, Celldex, Astex, Analogic, Amarin, Alnylam, Alexion, AcelRx
[video] Why Roche May Want to Acquire Alexion
Bloomberg
Monday, July 15, 2013 - 11:16am
tags:
Roche, Alexion, M&A, Soliris
Tiny Biotech With Three Cancer Drugs Is More Alluring Takeover Bet Now
Forbes
Monday, July 15, 2013 - 11:14am
tags:
Spectrum Pharmaceuticals, Fusilev, Folotyn, Zevalin, cancer
Vivus Delays Annual Meeting on Eve of Board Proxy Vote
Bloomberg
Monday, July 15, 2013 - 10:36am
tags:
Vivus
FDA Grants QIDP Designation to Eravacycline, Tetraphase’s Lead Antibiotic Product Candidate
Yahoo
Monday, July 15, 2013 - 10:29am
tags:
Eravacycline, Tetraphase Pharmaceuticals, antiobiotics, QIDP
Expect Huge Upside to This Biotech Stock as It Approaches FDA Approval
Motley Fool
Monday, July 15, 2013 - 10:27am
tags:
FDA, AstraZeneca, Novartis, Acadia, pimavanserin
Johnson & Johnson (JNJ) Earnings Projected to Increase
Forbes
Monday, July 15, 2013 - 10:25am
tags:
JNJ, earnings
Vote of confidence for Astex Pharma
Yahoo/optionMONSTER
Monday, July 15, 2013 - 10:19am
tags:
Astex
Abbott to Buy Eye Laser, Stent Companies for About $560 Million
Bloomberg
Monday, July 15, 2013 - 10:12am
tags:
Abbott Laboratories, M&A, Idev Technologies, OptiMedica
New vaccine may save day for ill passengers
Star Phoenix, Canada
Sunday, July 14, 2013 - 11:39am
tags:
norovirus, Takeda, vaccines
New drug pricing policy (in India) may hit revenues up to 5%: Dr Reddy's
Zee News, India
Sunday, July 14, 2013 - 11:36am
tags:
Dr Reddy's
Sanofi emerges top bidder for Elder Pharma business
Economic Times, India
Sunday, July 14, 2013 - 11:26am
tags:
Sanofi, M&A, Elder Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.